0.0062USD+3.33%Mkt Cap: 258470 USDP/E: 0.00Last update: 2026-05-26
Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary software as a service (SaaS) platform and Software as a medical device web application designed to assist pha…
Industry Peers
Drug Manufacturers - Specialty & Generic155.29BSEKP/E 172.0
58.11BTRYP/E 27.8
56.52BEURP/E 22.3
33.63BPLNP/E 21.9
24.50BUSDP/E 21.3
18.90BUSD—
15.76BUSDP/E 24.1
13.30BSEKP/E 40.0
Indicators:|
Key Statistics
Company
Market Cap258.47K USD
Enterprise Value-4.08M USD
Revenue (TTM)—
Gross Profit0 USD
Net Income (TTM)1.91M USD
Revenue/Share—
Last Price0.0062 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees3
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)0.00
P/E (Forward)-0.01
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.09
EPS (TTM)6.64
EPS (Forward)-1.09
52W Range
0.00208% of range0.0560
52W High0.0560 USD
52W Low0.0020 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE66.66%
ROA37.06%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.73M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-8257.43%
Net Debt-4.35M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio1.68
Quick Ratio1.66
Book Value/Sh0.0680 USD
Cash/Share0.1030 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateMay 1, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.42.37M
Float36.25M
Insiders17.89%
Institutions10.24%
Short Interest
Short Ratio0.2d
Short % Float25.07%
Short % Out.24.06%
Shares Short493.83K
Short (prev mo.)59.27K
Technical
SMA 500.0067 (-7.5%)
SMA 2000.0143 (-56.7%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)120.36K
Avg Vol (10d)72.67K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—